ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0388

Joint Association of Triglyceride-Glucose Index and Systemic Inflammation Index with Mortality in Cardiovascular-Kidney-Metabolic Syndrome Stages 0-3: NHANES, 1999-2018

Session Information

Category: Cardiovascular-Kidney-Metabolic Health

  • 602 Cardiovascular-Kidney-Metabolic Health: Clinical

Authors

  • Duo, Lijin, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
  • Su, Hua, Huazhong University of Science and Technology Tongji Medical College, Wuhan, Hubei, China
Background

To investigate the combined impact of triglyceride glucose (TyG) index and systemic immune-inflammation index (SII) on mortality risk in patients with cardiovascular-kidney-metabolic (CKM) syndrome.

Methods

This study enrolled 12633 participants with stages 0-3 CKM syndrome at baseline from NHANES. Participants were stratified by the median TyG and SII values. Kaplan-Meier (K-M) curves, multivariate Cox proportional hazards models, and restricted cubic spline (RCS) regression were used to assess their associations with mortality. The interaction between TyG and SII was also evaluated. Subgroup and sensitivity analyses were further conducted to verify result reliability.

Results

Compared with participants with low TyG and low SII, the fully adjusted hazard ratio (HR) for all-cause mortality was 2.01 (95% CI: 1.58–2.56), and for CVD mortality was 2.39 (95% CI: 1.48–3.86) among those with high TyG and high SII. The combination of TyG and SII improved the predictive performance for mortality compared with either biomarker alone. Consistent results were found in subgroup and sensitivity analyses.

Conclusion

TyG index and SII were strongly associated with all-cause and CVD mortality in stage 0–3 CKM syndrome. Their combination effectively improved predictive performance.

Kaplan-Meier curves were constructed to evaluate all-cause mortality (A) and CVD mortality (B) among various TyG-SII subgroups.

Restricted cubic spline analyses of TyG index and SII in relation to all-cause and CVD mortality (A–D).

Funding

  • Government Support – Non-U.S.